Top compounds associated with response to NRG2


Feature Type Standardized
Nominal ANOVA
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.063 0.04
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.04
mRNA AZD7762 GDSC1000 pan-cancer AAC -0.065 0.04
mRNA ML258 CTRPv2 pan-cancer AAC -0.076 0.04
mRNA NVP-BEZ235 CTRPv2 pan-cancer AAC 0.085 0.04
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.068 0.04
mRNA Sorafenib GDSC1000 pan-cancer AAC -0.11 0.04
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.04
mRNA Carboplatin CTRPv2 pan-cancer AAC -0.073 0.04
mRNA RITA CTRPv2 pan-cancer AAC -0.072 0.04
Download CSV